PUBLICATION
            Expression of pathogenic SCN9A mutations in the zebrafish: A model to study small fiber neuropathy
- Authors
- Eijkenboom, I., Sopacua, M., Otten, A.B.C., Gerrits, M.M., Hoeijmakers, J.G.J., Waxman, S.G., Lombardi, R., Lauria, G., Merkies, I.S.J., Smeets, H.J.M., Faber, C.G., Vanoevelen, J.M., PROPANE Study Group
- ID
- ZDB-PUB-181015-1
- Date
- 2018
- Source
- Experimental neurology 311: 257-264 (Journal)
- Registered Authors
- Keywords
- Nerve density, SCN9A mutations, Small fiber neuropathy, Temperature assay, Zebrafish model
- MeSH Terms
- 
    
        
        
            
                - Female
- Humans
- Mutation/genetics*
- Gene Expression
- Zebrafish
- Disease Models, Animal*
- Small Fiber Neuropathy/genetics*
- Small Fiber Neuropathy/metabolism*
- Small Fiber Neuropathy/pathology
- Animals
- Male
- NAV1.7 Voltage-Gated Sodium Channel/biosynthesis*
- NAV1.7 Voltage-Gated Sodium Channel/genetics*
 
- PubMed
- 30316835 Full text @ Exp. Neurol.
            Citation
        
        
            Eijkenboom, I., Sopacua, M., Otten, A.B.C., Gerrits, M.M., Hoeijmakers, J.G.J., Waxman, S.G., Lombardi, R., Lauria, G., Merkies, I.S.J., Smeets, H.J.M., Faber, C.G., Vanoevelen, J.M., PROPANE Study Group (2018) Expression of pathogenic SCN9A mutations in the zebrafish: A model to study small fiber neuropathy. Experimental neurology. 311:257-264.
        
    
                
                    
                        Abstract
                    
                    
                
                
            
        
        
    
        
            
            
 
    
    
        
    
    
    
        
                Small fiber neuropathy (SFN) patients experience a spectrum of sensory abnormalities, including attenuated responses to non-noxious temperatures in combination with a decreased density of the small-nerve fibers. Gain-of-function mutations in the voltage-gated sodium channels SCN9A, SCN10A and SCN11A have been identified as an underlying genetic cause in a subpopulation of patients with SFN. Based on clinical-diagnostic tests for SFN, we have set up a panel of two read-outs reflecting SFN in zebrafish, being nerve density and behavioral responses. Nerve density was studied using a transgenic line in which the sensory neurons are GFP-labelled. For the behavioral experiments, a temperature-controlled water compartment was developed. This device allowed quantification of the behavioral response to temperature changes. By using these read-outs we demonstrated that zebrafish embryos transiently overexpressing the pathogenic human SCN9A p.(I228M) or p.(G856D) mutations both have a significantly decreased density of the small-nerve fibers. Additionally, larvae overexpressing the p.(I228M) mutation displayed a significant increase in activity induced by temperature change. As these features closely resemble the clinical hallmarks of SFN, our data suggest that transient overexpression of mutant human mRNA provides a model for SFN in zebrafish. This disease model may provide a basis for testing the pathogenicity of novel genetic variants identified in SFN patients. Furthermore, this model could be used for studying SFN pathophysiology in an in vivo model and for testing therapeutic interventions.
            
    
        
        
    
    
    
                
                    
                        Genes / Markers
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Expression
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Phenotype
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Mutations / Transgenics
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Human Disease / Model
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Sequence Targeting Reagents
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Fish
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Orthology
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Engineered Foreign Genes
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Mapping
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    